Takeaways From Fed. Circ. Hatch-Waxman IPR Case

On Jan. 11, 2019, the U.S. Court of Appeals for the Federal Circuit issued a precedential opinion in Amerigen Pharmaceuticals Ltd. v. UCB Pharma GmbH[1] affirming the decision of the Patent...

Already a subscriber? Click here to view full article